Evolus Inc (NASDAQ: EOLS) open the trading on Thursday, with great promise as it jumped 5.43% to $7.18, before settling in for the price of $6.81 at the close. Taking a more long-term approach, EOLS posted a 52-week range of $5.71-$17.44.
The Healthcare sector firm’s twelve-monthly sales growth has been 23.91% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 23.91%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -95.14%. This publicly-traded company’s shares outstanding now amounts to $64.77 million, simultaneously with a float of $50.78 million. The organization now has a market capitalization sitting at $464.44 million. At the time of writing, stock’s 50-day Moving Average stood at $6.68, while the 200-day Moving Average is $9.76.
Evolus Inc (EOLS) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. Evolus Inc’s current insider ownership accounts for 21.50%, in contrast to 85.98% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’25, this organization’s Chief Marketing Officer sold 5,722 shares at the rate of 7.51, making the entire transaction reach 42,972 in total value, affecting insider ownership by 89,949. Preceding that transaction, on Aug 15 ’25, Company’s Director bought 30,000 for 6.82, making the whole transaction’s value amount to 204,486. This particular insider is now the holder of 88,629 in total.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Let’s observe the current performance indicators for Evolus Inc (EOLS). It’s Quick Ratio in the last reported quarter now stands at 1.53. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.62.
In the same vein, EOLS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.91, a figure that is expected to reach 0.06 in the next quarter, and analysts are predicting that it will be 0.27 at the market close of one year from today.
Technical Analysis of Evolus Inc (EOLS)
[Evolus Inc, EOLS] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 48.90% While, its Average True Range was 65.55.
Raw Stochastic average of Evolus Inc (EOLS) in the period of the previous 100 days is set at 32.74%, which indicates a major fall in contrast to 65.48% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.40 that was higher than 0.35 volatility it exhibited in the past 100-days period.
